B L Gause Selected Research

B L Gause Research Topics

2	Neutropenia 04/2001 - 01/2000
1	Renal Cell Carcinoma (Grawitz Tumor) 04/2001
1	Anemia 04/2001
1	Melanoma (Melanoma, Malignant) 04/2001
1	Neoplasm Metastasis (Metastasis) 04/2001
1	Thrombocytopenia (Thrombopenia) 04/2001
1	Lymphoma (Lymphomas) 05/2000
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 05/2000
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 05/2000
1	Splenomegaly 05/2000
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2000
1	Hairy Cell Leukemia 01/2000

1	Topoisomerase I InhibitorsIBA 04/2001
1	Macrophage Colony-Stimulating FactorIBA 04/2001
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 04/2001
1	Topotecan (Hycamtin)FDA LinkGeneric 04/2001
1	Mechlorethamine (Nitrogen Mustard)FDA Link 05/2000
1	Methotrexate (Mexate)FDA LinkGeneric 05/2000
1	Cytarabine (Cytosar-U)FDA LinkGeneric 05/2000
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2000
1	Bleomycin (Blenoxane)FDA LinkGeneric 05/2000
1	Etoposide (VP 16)FDA LinkGeneric 05/2000
1	Immunotoxins (Immunotoxin)IBA 05/2000
1	Prednisone (Sone)FDA LinkGeneric 05/2000
1	RicinIBA 05/2000
1	Vincristine (Oncovin)FDA LinkGeneric 05/2000
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2000
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2000
1	Interferon-alpha (Interferon Alfa)IBA 01/2000
1	Pentostatin (Nipent)FDA LinkGeneric 01/2000

2	Drug Therapy (Chemotherapy) 04/2001 - 05/2000
1	Nephrectomy 04/2001
1	PROMACE-CytaBOM protocol 05/2000
1	Combination Drug Therapy (Combination Chemotherapy) 05/2000
1	Operative Surgical Procedures 05/2000
1	Therapeutics 05/2000
1	Salvage Therapy 01/2000